This page lists all pharmaceutical reports related to the field of Immunology & Inflammatory Diseases. The reports include market research reports and pipeline analyses.
Displaying 151 - 177 of 177 results
- Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
- ENT Disorders Market to 2016 - Increasing Resistance to Anti-Bacterials to Drive Development of Novel Therapies for ENT Disorders
- Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
- Gout Therapeutics Market to 2017- Entry of Novel Therapies such as Krystexxa, Uloric, Adenuric and Colcrys to Drive Market
- Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment
- Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market
- Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure
- Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development
- Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies
- Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
- Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers
- Anti-Inflammatory Therapeutics Market to 2017 - Respiratory Diseases and Arthritis Continue to Dominate
- Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010
- GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing
- Drug Delivery Device Market to 2017 - Metered Dose Inhalers and Infusion Pumps to be Key Revenue Generators
- Oral Mucositis Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Asthma Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Allergic Conjunctivitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Ulcerative Colitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Idiopathic Pulmonary Fibrosis (IPF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Chronic Obstructive Pulmonary Disease (COPD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Alopecia Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Atopic Dermatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Psoriasis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Type 1 Diabetes Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- RHEUMATOID ARTHRITIS: WORLD DRUG MARKET 2011-2021